Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.21.1
Earnings Per Share (Tables)
6 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted earnings per share
Three Months Ended
March 31,
Six Months Ended
March 31,
  2021 2020 2021 2020
Net income (loss) attributable to Hillenbrand $ 78.1  $ (74.0) $ 154.5  $ (77.1)
Weighted-average shares outstanding (basic - in millions) (1)
75.5  75.1  75.4  71.7 
Effect of dilutive stock options and other unvested equity awards (in millions) (2)
0.7  —  0.4  — 
Weighted-average shares outstanding (diluted - in millions) 76.2  75.1  75.8  71.7 
Basic earnings (loss) per share $ 1.04  $ (0.99) $ 2.05  $ (1.07)
Diluted earnings (loss) per share $ 1.03  $ (0.99) $ 2.04  $ (1.07)
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.5  3.1  0.8  2.8 
 
(1)The increase in weighted-average shares outstanding during the six months ended March 31, 2021 was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information.
(2)As a result of the net loss attributable to Hillenbrand during the three and six months ended March 31, 2020, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted earnings per share calculation.